References
  1. Smyth A, Elborn JS. Exacerbations in cystic fibrosis: 3–Management. Thorax. 2008 Feb;63(2):180-4. doi: 10.1136/thx.2006.060905. PMID: 18234661.
  2. Palleria C, Di Paolo A, Giofrè C, Caglioti C, Leuzzi G, et al. Pharmacokinetic drug-drug interaction and their implication in clinical management. J Res Med Sci. 2013 Jul;18(7):601-10. PMID: 24516494; PMCID: PMC3897029.
  3. Farooqui R, Hoor T, Karim N, Muneer M. Potential Drug-Drug Interactions among Patients prescriptions collected from Medicine Out-patient Setting. Pak J Med Sci. 2018 Jan-Feb;34(1):144-148. doi: 10.12669/pjms.341.13986. PMID: 29643896; PMCID: PMC5857000.
  4. Khandeparkar A, Rataboli PV. A study of harmful drug-drug interactions due to polypharmacy in hospitalized patients in Goa Medical College. Perspect Clin Res. 2017 Oct-Dec;8(4):180-186. doi: 10.4103/picr.PICR_132_16. PMID: 29109936; PMCID: PMC5654218.
  5. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, Hallisey R, Ives J, Laird N, Laffel G, et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995 Jul 5;274(1):35-43. PMID: 7791256.
  6. Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med. 2015 Apr 7;13:74. doi: 10.1186/s12916-015-0322-7. PMID: 25889849; PMCID: PMC4417329.
  7. Jazbar J, Locatelli I, Horvat N, Kos M. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study. Res Social Adm Pharm. 2018 Jun;14(6):572-580. doi: 10.1016/j.sapharm.2017.07.004. Epub 2017 Jul 11. PMID: 28716467.
  8. Shah PH, Lee JH, Salvi DJ, Rabbani R, Gavini DR, Hamid P. Cardiovascular System Involvement in Cystic Fibrosis. Cureus. 2021 Jul 29;13(7):e16723. doi: 10.7759/cureus.16723. PMID: 34513358; PMCID: PMC8405250.
  9. Skolnik K, Levy RD, Wilcox PG, Quon BS. Coronary artery disease in cystic fibrosis: An emerging concern? J Cyst Fibros. 2016 Nov;15(6):e70-e71. doi: 10.1016/j.jcf.2016.09.010. Epub 2016 Oct 14. PMID: 27751792.
  10. Nolan PE Jr, Marcus FI. Cardiovascular Drug Use in the Elderly. Am J Geriatr Cardiol. 2000 May;9(3):127-129. doi: 10.1111/j.1076-7460.2000.80021.x. PMID: 11416550.
  11. BNF (only available in the UK). NICE. Available at: https://bnf.nice.org.uk/ (Accessed: December 11, 2022).
  12. Cascorbi I. Drug interactions–principles, examples and clinical consequences. Dtsch Arztebl Int. 2012 Aug;109(33-34):546-55; quiz 556. doi: 10.3238/arztebl.2012.0546. Epub 2012 Aug 20. PMID: 23152742; PMCID: PMC3444856.
  13. Patel VK, Acharya LD, Rajakannan T, Surulivelrajan M, Guddattu V, Padmakumar R. Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital. Australas Med J. 2011;4(1):9-14. doi: 10.4066/AMJ.2011.450. Epub 2011 Jan 31. PMID: 23393498; PMCID: PMC3562967.
  14. Sweileh WM, Sawalha AF, Jaradat NA. Extent of potential drug interactions among patients receiving anti-hypertensive medications. Saudi Med J. 2005 Apr;26(4):548-52. PMID: 15900357.
  15. Vonbach P, Dubied A, Krähenbühl S, Beer JH. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine. Eur J Intern Med. 2008 Oct;19(6):413-20. doi: 10.1016/j.ejim.2007.12.002. Epub 2008 Feb 7. PMID: 18848174.
  16. Mar PL, Horbal P, Chung MK, Dukes JW, Ezekowitz M, et al; from the American Heart Association Electrocardiography and Arrhythmias Committee of the Council of Clinical Cardiology. Drug Interactions Affecting Antiarrhythmic Drug Use. Circ Arrhythm Electrophysiol. 2022 May;15(5):e007955. doi: 10.1161/CIRCEP.121.007955. Epub 2022 May 2. PMID: 35491871.
  17. Leone R, Magro L, Moretti U, Cutroneo P, Moschini M, et al. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy. Drug Saf. 2010 Aug 1;33(8):667-75. doi: 10.2165/11534400-000000000-00000. PMID: 20635825.
  18. Hallas J, Harvald B, Gram LF, Grodum E, Brøsen K, Haghfelt T, Damsbo N. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990 Aug;228(2):83-90. doi: 10.1111/j.1365-2796.1990.tb00199.x. PMID: 2394974.
  19. Bergman U, Wiholm BE. Drug-related problems causing admission to a medical clinic. Eur J Clin Pharmacol. 1981;20(3):193-200. doi: 10.1007/BF00544597. PMID: 7286037.